Live from the NIH registry
Studies recruiting near Shreveport right now
Top 25 of 167 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Overton Brooks Veteran's Administration Medical Center — Shreveport, Louisiana (4.9 mi)
· Sponsor: SWOG Cancer Research Network
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Shreveport, Louisiana (4.9 mi)
· Sponsor: AstraZeneca
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 710 participants sought
Trials365 LLC — Shreveport, Louisiana (4.9 mi)
· Sponsor: Daiichi Sankyo
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
Christus Highland/ Boniol — Shreveport, Louisiana (4.9 mi)
· Sponsor: Guardant Health, Inc.
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Louisiana State University Health Sciences Shreveport ( Site 0029) — Shreveport, Louisiana (4.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
Collaborative Multi-level Obesity Intervention Engaging Underserved Communities Trial
Obesity
N/A
Interventional 522 participants sought
David Raines Community Health Center - Shreveport Clinic — Shreveport, Louisiana (4.9 mi)
· Sponsor: Tulane University
Stroke Thrombectomy and Aneurysm Registry
Stroke, Thromboses, Intracranial
N/A
Observational 40,000 participants sought
Louisiana State University Health Shreveport — Shreveport, Louisiana (4.9 mi)
· Sponsor: Medical University of South Carolina
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Liver Neoplasms, Primary Liver Cancer
N/A
Observational 5,000 participants sought
Willis Knighton Health — Shreveport, Louisiana (4.9 mi)
· Sponsor: HistoSonics, Inc.
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Cardiovascular Solutions, LLC — Shreveport, Louisiana (4.9 mi)
· Sponsor: Duke University
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
IgAN, C3G
Phase 2
Interventional 45 participants sought
ADARx Clinical Site — Shreveport, Louisiana (4.9 mi)
· Sponsor: ADARx Pharmaceuticals, Inc.
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Overton Brooks V.A. Medical Center — Shreveport, Louisiana (4.9 mi)
· Sponsor: Novo Nordisk A/S
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Cervical Cancer
Phase 3
Interventional 1,023 participants sought
TRIALS 365 ( Site 6008) — Shreveport, Louisiana (4.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
Registry Study for Radiation Therapy Outcomes
Neoplasms
N/A
Observational 50,000 participants sought
Willis-Knighton Cancer and Proton Therapy Center — Shreveport, Louisiana (4.9 mi)
· Sponsor: Proton Collaborative Group
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Ochsner LSU Health Saint Mary's Medical Center — Shreveport, Louisiana (4.9 mi)
· Sponsor: SWOG Cancer Research Network
Prospective Evaluation of Complex Adult Spinal Deformity (CAD) Treated With Minimally Invasive Surgery
Adult Spinal Deformity, Scoliosis
N/A
Observational 500 participants sought
Louisiana Spine Institute — Shreveport, Louisiana (4.9 mi)
· Sponsor: International Spine Study Group Foundation
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Shreveport, Louisiana (4.9 mi)
· Sponsor: Medtronic
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Breast Cancer
N/A
Observational 30,000 participants sought
Louisiana State University — Shreveport, Louisiana (4.9 mi)
· Sponsor: Agendia
STimulation to Activate RespIration
ARDS (Moderate or Severe), AHRF
N/A
Interventional 30 participants sought
Louisiana State University Health Sciences — Shreveport, Louisiana (4.9 mi)
· Sponsor: Lungpacer Medical Inc.
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Sleep Apnea, Obstructive, Obesity
Phase 3
Interventional 800 participants sought
Care Access - Shreveport 2 — Shreveport, Louisiana (4.9 mi)
· Sponsor: Eli Lilly and Company
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
Benign Prostatic Hyperplasia
N/A
Interventional 92 participants sought
Ochsner LSU Health Shreveport - Regional Urology — Shreveport, Louisiana (4.9 mi)
· Sponsor: Urotronic Inc.
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
Phase 4
Interventional 350 participants sought
GSK Investigational Site — Shreveport, Louisiana (4.9 mi)
· Sponsor: GlaxoSmithKline
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Obesity
Phase 3
Interventional 1,200 participants sought
Kailera Clinical Site — Shreveport, Louisiana (4.9 mi)
· Sponsor: Kailera
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
Lupus Nephritis
Phase 2
Interventional 40 participants sought
Louisiana State University — Shreveport, Louisiana (4.9 mi)
· Sponsor: Hoffmann-La Roche
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Ulcerative Colitis, Obesity or Overweight
Phase 3
Interventional 350 participants sought
Louisiana Research Center — Shreveport, Louisiana (4.9 mi)
· Sponsor: Eli Lilly and Company
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Relapsed or Refractory Multiple Myeloma
Phase 3
Interventional 810 participants sought
Local Institution - 0385 — Shreveport, Louisiana (4.9 mi)
· Sponsor: Celgene